Coronavirus company news summary – Philanthropists partner to provide ventilators to Africa – Julian Jewel Jeyaraj develops online app to aid doctors

28 May 2020 (Last Updated May 28th, 2020 09:55)

Biocon’s subsidiary Biocon Biologics has received approval from the Drugs Controller General of India for an extracorporeal blood purification (EBP) device CytoSorb. The device is designed to decrease pro-inflammatory cytokines levels in patients who have Covid-19 and are in the intensive care unit (ICU) for confirmed or imminent respiratory failure.

Julian Jewel Jeyaraj has launched an online application to aid doctors and to diagnose Covid-19 coronavirus with a CT scan. The app, Julian Jewel’s Artificial Intelligence Bot (JJAIBOT), was launched after the pandemic worsened and can be accessed from any part of the world. The app uses two parameters to diagnose patients with Covid-19: X-ray PA view of the chest and CT scan of the lungs.

A global team of philanthropists have partnered to provide urgently needed ventilators, breathing support devices and other medical equipment to African nations to aid in the fight against Covid-19 pandemic. Higherlife Foundation co-founder Strive Masiyiwa is heading the private partnership to begin manufacturing of the equipment locally. The initiative will produce 1,000 bridge ventilators initially. The design of the ventilators will be provided free by Virgin Orbit, has been approved by the US Food and Drug Administration (FDA).

The FDA has issued SARS-CoV-2 reference panel to aid its evaluation of Covid-19 diagnostic tests. Reference panels offer an extra measure to ensure the test quality, new assay validation, test calibration and monitoring of the performance of the assay. The reference panel is an independent performance validation step for Covid-19 tests used in a clinical setting and not for research.